Finding the Achilles' Heel of AIDS

Courtesy of the Michael H. Malim LabFor about 10 years, our laboratory had been trying to elucidate why the HIV Vif protein is essential for virus replication. Since 1998, we had suspected that Vif 's role was to inhibit a cellular protein that naturally blocks infection. This scintillation counter printout from December 2001 shows that varying amounts of a candidate inhibitor gene we had identified, called APOBEC3G/CEM15, profoundly suppress infection (measured as radioactivity in the CPM colum

Written byMichael Malim
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of the Michael H. Malim Lab

For about 10 years, our laboratory had been trying to elucidate why the HIV Vif protein is essential for virus replication. Since 1998, we had suspected that Vif 's role was to inhibit a cellular protein that naturally blocks infection. This scintillation counter printout from December 2001 shows that varying amounts of a candidate inhibitor gene we had identified, called APOBEC3G/CEM15, profoundly suppress infection (measured as radioactivity in the CPM column) by Vif-deficient HIV (samples 8 to 12) but not by wild-type virus (samples 2 to 6). The calculations of fold-inhibition are hand-written to the right and samples 7 and 13 are positive controls. What particularly amuses us about the initial record of this discovery is Ann's understated, handwritten conclusion, and the recognition that repetition was crucial!

- Michael H. Malim & Ann M. Sheehy King's College London

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies